Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
Appointed director
|
|
AVROBIO, Inc. (AVRO)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/21/2020 |
8-K
| Appointed a new director|
Docs:
|
"AVROBIO Appoints Dr. Gail Farfel to its Board of Directors CAMBRIDGE, Mass.—Oct. 21, 2020—AVROBIO, Inc. , a leading clinical-stage gene therapy company with a mission to free people from a lifetime of genetic disease, today announced the appointment of Gail M. Farfel, Ph.D., to its Board of Directors. Dr. Farfel brings more than 25 years of pharmaceutical development and regulatory experience in rare diseases with both large and small pharmaceutical companies. “Gail's deep experience in rare disease, with a focus on neuroscience, and her expertise in leading global product development and regulatory approvals is highly relevant to our growing pipeline of investigational gene therapies that target lysosomal disorders, devastating disorders that impact both the body and brain,” said Geoff Ma..." |
|
| 01/07/2019 |
8-K
| Quarterly results |
| 06/25/2018 |
8-K
| Appointed a new director |
|
|